ASPECT BIOSYSTEMS
Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease. By combining its proprietary microfluidic 3D bioprinting technology, therapeutic cells, and materials science, Aspect is creating a pipeline of allogeneic cell-based tissue therapeutics to replace or repair damaged organ functions. The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.
ASPECT BIOSYSTEMS
Industry:
Biotechnology Life Science
Founded:
2013-11-19
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.aspectbiosystems.com
Total Employee:
51+
Status:
Active
Contact:
604-263-0502
Total Funding:
81.07 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager Google Analytics Content Delivery Network Global Site Tag
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Advisors List
Advisor
2022-06-01
Board_member
2022-09-01
Advisor
2013-11-01
Board_member
Board_member
2020-01-01
Board_member
2022-09-01
Advisor
Board_member
2022-09-01
Current Employees Featured
Tamer Mohamed Co-founder & CEO @ Aspect Biosystems
Co-founder & CEO
2016-05-01
Simon Beyer Co-founder & Chief Technology Officer @ Aspect Biosystems
Co-founder & Chief Technology Officer
2019-02-01
Sam Wadsworth Co-founder & Chief Scientific Officer @ Aspect Biosystems
Co-founder & Chief Scientific Officer
2013-10-01
Ray Smith Chief Financial Officer @ Aspect Biosystems
Chief Financial Officer
2020-11-01
Rafal Witek VP, Translational Sciences @ Aspect Biosystems
VP, Translational Sciences
2021-09-01
Spiro Getsios Senior VP, Preclinical R&D @ Aspect Biosystems
Senior VP, Preclinical R&D
2018-09-01
Eric Roos Chief Business Development Officer @ Aspect Biosystems
Chief Business Development Officer
2020-05-01
Jack Harvey Senior VP, Process Development & Manufacturing @ Aspect Biosystems
Senior VP, Process Development & Manufacturing
2021-09-01
Founder
Investors List
Government of British Columbia
Government of British Columbia investment in Grant - Aspect Biosystems
Government of Canada
Government of Canada investment in Grant - Aspect Biosystems
Novo Nordisk
Novo Nordisk investment in Convertible Note - Aspect Biosystems
Pacific Economic Development Canada
Pacific Economic Development Canada investment in Grant - Aspect Biosystems
Page One Ventures
Page One Ventures investment in Venture Round - Aspect Biosystems
Stem Cell Network (SCN)
Stem Cell Network (SCN) investment in Grant - Aspect Biosystems
Innovate BC
Innovate BC investment in Grant - Aspect Biosystems
Pallasite Ventures
Pallasite Ventures investment in Series A - Aspect Biosystems
Rhino Ventures
Rhino Ventures investment in Series A - Aspect Biosystems
Radical Ventures
Radical Ventures investment in Series A - Aspect Biosystems
Key Employee Changes
| Date | New article |
|---|---|
| 2020-07-21 | Aspect Biosystems Appoints Eric Roos as Chief Business Development Officer |
Official Site Inspections
http://www.aspectbiosystems.com Semrush global rank: 4.16 M Semrush visits lastest month: 2.46 K
- Host name: ec2-35-183-91-107.ca-central-1.compute.amazonaws.com
- IP address: 35.183.91.107
- Location: Montreal Canada
- Latitude: 45.4995
- Longitude: -73.5848
- Timezone: America/Toronto
- Postal: H3G
More informations about "Aspect Biosystems"
Our Story - Aspect Biosystems
As Chief Technology Officer at Aspect Biosystems, Simon oversees the advancement of our biomanufacturing technologies. He co-founded the company in 2013 and currently leads our …See details»
Join our Team - Aspect Biosystems
Working at Aspect means knowing that you are making an impact on the organization as an individual, and that the organization itself is making a meaningful impact in the world. Tackle …See details»
Aspect Biosystems - Crunchbase Company Profile
Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease. By combining its proprietary microfluidic 3D bioprinting technology, therapeutic cells, and materials …See details»
Aspect Biosystems - LinkedIn
Aspect Biosystems | 20,351 followers on LinkedIn. Developing bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. | Aspect Biosystems is a biotechnology ...See details»
Aspect Biosystems - PitchBook
Www.aspectbiosystems.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 887 Great Northern Way; Suite 500; Vancouver, British Columbia V5T 4T5; CanadaSee details»
Aspect Biosystems Raises US$115 Million Series B ... - Business Wire
1 day ago Natalie Korenic Aspect Biosystems media@aspectbiosystems.com. Release Summary. Aspect Biosystems secures $115M Series B to advance bioprinted tissue …See details»
Aspect Biosystems, Author at Life Sciences British Columbia
Website www.aspectbiosystems.com; Phone +1 (604) 263 0502 Email info@aspectbiosystems.com; Address 887 Great Northern Way, #500 Vancouver, BC …See details»
Aspect Biosystems - Company Profile - Tracxn
Dec 26, 2024 Website: aspectbiosystems.com; Social: Key Metrics. Total Funding. $23.7M in 5 rounds. Latest Funding Round. Series A, Jan 09, 2020, $20M. Investors. Pangaea Ventures & …See details»
Aspect Biosystems Announces $200 Million Partnership with the ...
Jul 10, 2024 Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating serious metabolic and …See details»
Get in Touch | Aspect Biosystems
Get in touch.. 887 Great Northern Way, #500 Vancouver BC, Canada V5T 4T5 +1 604 263 0502. General Inquiries. info@aspectbiosystems.com; PR & Media Inquiries. media@aspectbiosystems.comSee details»
Aspect Biosystems – an Unreasonable company
Aspectbiosystems.com Employees 21–50 Headquarters Vancouver, British Columbia, Canada Aspect Biosystems is a biotechnology company creating bioprinted tissue therapeutics to …See details»
Aspect Biosystems Company Profile - Office Locations ... - Craft
Aspect Biosystems has 5 employees at their 1 location and $23.7 m in total funding,. See insights on Aspect Biosystems including office locations, competitors, revenue, financials, executives, …See details»
Aspect Biosystems Company Profile | Management and Employees …
Smith@aspectbiosystems.com: Aspect Biosystems Top Competitors. Company Employees Revenue Top technologies; Inventia Life Science Pty Ltd. n/a: $12.5 M: Solarvest BioEnergy …See details»
Aspect Biosystems Appoints Three New Board Members
The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine. Learn more at aspectbiosystems.com. …See details»
What is Aspect Biosystems? Company Culture, Mission, Values
Mission: Transforming medicine with bioprinted cell therapies. Aspect Biosystems is pioneering the development of implantable, bioprinted cell therapies as medicines of the future. These …See details»
Aspect Biosystems Raises US$115 Million Series B Financing to …
1 day ago VANCOUVER, British Columbia — Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics as a new category in …See details»
Aspect Biosystems Company Overview, Contact Details
Jul 10, 2024 Strategic Government Funding Aspect Biosystems has received substantial government funding, totaling over $320 million, indicating strong support for the company's …See details»
Aspect Biosystems Raises US$115 Million Series B Financing to …
1 day ago Aspect’s pipeline development strategy involves both proprietary programs as well as strategic partnerships, including a collaboration with Novo Nordisk focused on diabetes and …See details»
Aspect Biosystems Raises US$115 Million Series B Financing to …
1 day ago Aspect's pipeline development strategy involves both proprietary programs as well as strategic partnerships, including a collaboration with Novo Nordisk focused on diabetes and …See details»
Recommended Stories - Yahoo Finance
1 day ago VANCOUVER, British Columbia, January 08, 2025--Aspect Biosystems secures $115M Series B to advance bioprinted tissue therapeutics, accelerating development of …See details»